These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20806127)

  • 1. Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors.
    Ruinemans-Koerts J; Peterse-Stienissen I; Verbruggen B
    Thromb Haemost; 2010 Nov; 104(5):1080-2. PubMed ID: 20806127
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G; Jayakodi D; Dunkley S
    Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
    Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
    [No Abstract]   [Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Lupus anticoagulant" in immune hyperthyroidism].
    Schuler G; Alexopoulos A; Hasler K; Kerp L
    Dtsch Med Wochenschr; 1990 Oct; 115(40):1511-4. PubMed ID: 2120025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory identification of factor inhibitors: an update.
    Kershaw G; Favaloro EJ
    Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays.
    Tichelaar V; de Jong H; Nijland H; Kluin-Nelemans H; Meijer K; Mulder A
    Thromb Haemost; 2011 Nov; 106(5):990-2. PubMed ID: 21901233
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen.
    Verbruggen B; van Heerde WL; Laros-van Gorkom BA
    Semin Thromb Hemost; 2009 Nov; 35(8):752-9. PubMed ID: 20169511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group.
    Nuss R; Jacobson L; Hathaway WE; Manco-Johnson M
    Thromb Haemost; 1999 Nov; 82(5):1559-60. PubMed ID: 10595659
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
    Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
    Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating anticoagulants.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():65-70. PubMed ID: 785117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the partial thromboplastin time for the clinical diagnosis].
    Norpoth L; Surmann T; Schulze M
    Dtsch Med Wochenschr; 1968 Jul; 93(30):1437-8 passim. PubMed ID: 5668255
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays.
    Prowse CV; Chirnside A; Elton RA
    Thromb Haemost; 1980 Feb; 42(5):1355-67. PubMed ID: 6768149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.